Diffusion Pharmaceuticals, a Charlottesville, Va.-based developer of a drug candidate for enhancing oxygen diffusion, has raised $5.9 million in new VC and convertible note financing from undisclosed investors. It has now raised over $11.6 million in total funding.
2 min read · 01 February 2010
Pearl Therapeutics, a Redwood City, Calif.-based drug developer focused on respiratory disorders, has raised $15 million in Series C funding from return backers Clarus Ventures, New Leaf Venture Partners and 5AM Ventures. It previously raised around $35.5 million, plus $8 million in venture debt.
3 min read · 01 February 2010
SAIC (NYSE: SAI) has agreed to buy the online interactive virtual environment product line (Olive) of Forterra Systems Inc., for an undisclosed amount. Forterra has raised around $65 million in VC funding from firms like GC&H Investments, Sutter Hill Ventures, JVP, In-Q-Tel and Stanford University. Late last month, it reportedly laid off approximately half of its workforce, in anticipation of a sale.
2 min read · 01 February 2010
UPEK Inc., a Berkeley, Calif.-based developer of silicon-based fingerprint security solutions, has offered to merge with AuthenTec Inc. (Nasdaq: AUTH). The stock-for-stock merger would result in each company's shareholders owning a 50% stake in the combined company, with AuthenTec backers also to receive a $40 million cash dividend. UPEK has raised over $38 million in VC funding since being spun out of STMicroelectronics NV (STM) in 2004. Shareholders include Sofinnova Ventures, Sofinnova Partners, Diamondhead Ventures, Earlybird Venture Capital, Partners Group and EDBV Management.
7 min read · 01 February 2010
Columb Technologies Inc., a Campbell, Calif.-based developer of recharge solutions for electric cars, has raised $14 million in Series B funding. Voyager Capital and Rho Ventures co-led the round, and were joined by Siemens Venture Capital and Hartford Ventures. Columb previously raised a $3.75 million Series A round led by Estag Capital.
4 min read · 01 February 2010
Marten Mickos, former CEO of MySQL AB, has joined Index Ventures as an entrepreneur-in-residence. He also serves in a similar position with Benchmark Capital.
2 min read · 01 February 2010
4 min read · 30 January 2010
Flexion Therapeutics, a Woburn, Mass.-based drug development startup, has raised $9 million in new Series A funding from Pfizer's venture capital group. This brings the round total to $42 million, including a previously-announced first close from Versant Ventures, 5AM Ventures and Sofinnova Ventures.
3 min read · 29 January 2010
1 min read · 29 January 2010
EDGAR Online Inc. (Nasdaq: EDGR), a distributor of public company financial filings, has agreed to sell $12 million worth of convertible stock to Bain Capital Ventures, via a private placement. Jeff Schwartz and John Connolly of Bain Capital Ventures will join the EDGAR Online board of directors.
4 min read · 29 January 2010
